Avid Bioservices Inc (CDMO)

[cheynew]

Taylor Schreiber's HTBX had quite a nice run yesterday (up 30% on 10X normal volume) on their announcement:
Heat Biologics to Present Topline HS-110/Nivolumab Combination Phase Ib Lung Cancer Results at the International Society for the Study of Lung Cancer Annual Meeting plus they will present a poster reporting topline results, including primary endpoint data, from the Phase II trial evaluating HS-410 (vesigenurtacel-L) in combination with standard of care, Bacillus Calmette-Guérin (BCG), in the treatment of non-muscle invasive bladder cancer (NMIBC) at the Society of Urology Annual Meeting, in San Antonio, TX, on Wednesday, Nov 30th.

When was the last time we jumped 30%?

I looked at Rahul Jasuja's LinkedIn and the only active thing he shows is being a member of the BOD of Pelican Therapeutics. Is that a full time job? He added alot to the PPHM conference calls when he was at Noble.